Clinical News: Page 1743

PET/MRI tops PET/CT in abdominopelvic lesion conspicuity
By Wayne Forrest
Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK08-09 | Room S504CDPET/MRI with ultrafast gradient-recalled echo and spin-echo sequences is superior to PET/CT for lesion conspicuity, thus potentially improving therapy for patients with abdominopelvic cancer, according to a study by Swiss researchers.
November 7, 2012
FDG-PET/CT helps assess pancreatic cancer recurrence
By Wayne Forrest
Wednesday, November 28 | 11:30 a.m.-11:40 a.m. | SSK13-07 | Room S505ABFDG-PET/CT has "excellent accuracy" in detecting a recurrence following resection of pancreatic cancer, and maximum standardized uptake values can be used in determining the prognosis of these patients, according to researchers from India.
November 7, 2012
FDG-PET/CT plays key role in treatment outcomes of prostate cancer
By Wayne Forrest
Wednesday, November 28 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABA preliminary study by researchers at the University of Southern California suggests that FDG-PET/CT provides unique prognostic information on outcomes for men with castrate-sensitive metastatic prostate cancer who are undergoing various forms of hormonal treatment.
November 7, 2012
Virtual FDG-PET/CT software shows hard-to-find malignancies
By Wayne Forrest
Wednesday, November 28 | 10:30 a.m.-10:40 a.m. | SSK13-01 | Room S505ABResearchers from the University of Düsseldorf in Germany have developed virtual FDG-PET/CT panendoscopy software for the upper airways that they say can detect pharyngeal and laryngeal malignancies.
November 7, 2012
DOTATATE-PET/CT helps detect pancreatic neuroendocrine tumors
By Wayne Forrest
Monday, November 26 | 11:50 a.m.-12:00 p.m. | SSC13-09 | Room 505ABIn this retrospective study from University of Munich Hospital, researchers found that DOTATATE-PET/CT detects pancreatic neuroendocrine tumors better than MRI.
November 7, 2012
Microbubble US helps early assessment of liver dysplasia
By Wayne Forrest
Monday, November 26 | 11:30 a.m.-11:40 a.m. | SSC09-07 | Room S504CDIn this presentation, German researchers will discuss their preliminary success with an ultrasound contrast agent -- known as BR55 -- that uses microbubbles targeting vascular endothelial growth factor receptor 2 to assess liver dysplasia.
November 7, 2012
PET/MRI outshines PET/CT in lesion detection
By Wayne Forrest
Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC13-04 | Room S505ABPET/MRI showed superior lesion detectability compared to contrast-enhanced PET/CT in this study from King Fahad Specialist Hospital in Dammam, Saudi Arabia. Based on the results, researchers concluded that PET/MRI may be useful for abdominal lesion staging while sparing patients from contrast media.
November 7, 2012
NaF-PET/CT detects more skeletal lesions in advanced breast cancer cases
By Wayne Forrest
Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC09-04 | Room S504CDF-18 sodium fluoride (NaF) PET/CT detects more skeletal lesions than technetium-99m methylene diphosphonate SPECT in patients newly diagnosed with breast cancer, according to researchers from India.
November 7, 2012
FDG-PET/CT predicts response to chemo in breast cancer patients
By Wayne Forrest
Sunday, November 25 | 11:55 a.m.-12:05 p.m. | SSA18-08 | Room S505ABIn this presentation, Japanese researchers will discuss the ability of FDG tumor uptake at baseline and after neoadjuvant chemotherapy to predict pathological complete response and disease-free survival after surgery.
November 7, 2012
PET/CT helps with bone scans in staging breast cancer
By Wayne Forrest
Sunday, November 25 | 11:45 a.m.-11:55 a.m. | SSA18-07 | Room S505ABPET/CT can provide sufficient information from bone scans for the staging or restaging of breast cancer, according to a retrospective study by researchers from University Hospital Mannheim.
November 7, 2012
PET/MRI offers diagnostic accuracy for lymph node staging
By Wayne Forrest
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA12-04 | Room S504CDPET/MRI provides sufficient diagnostic accuracy for lymph node metastases detection, while diffusion-weighted MRI images are inaccurate for staging in head and neck cancer patients, according to researchers from the University of Düsseldorf.
November 7, 2012
FDG-PET/CT beats conventional imaging for breast cancer staging
By Wayne Forrest
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABGerman researchers retrospectively compared the diagnostic accuracy of whole-body FDG-PET/CT for initial breast cancer staging with the accuracy of conventional imaging using several different modalities. They will present their findings in this Sunday presentation.
November 7, 2012
Previous Page
Page 1743 of 3668
Next Page